Safinamide for Levodopa-induced Dyskinesia (PD-LID)

NCT03987750 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped drug development plan has been updated

Conditions

Dyskinesia, Drug-Induced
Parkinson Disease

Interventions

DRUG: Safinamide Methanesulfonate 150mg
DRUG: Safinamide Methanesulfonate 100mg
DRUG: Safinamide Methanesulfonate matching placebo

Sponsor

Zambon SpA